Rice Hall James & Associates’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Rice Hall James & Associates’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-119,426	Closed	-$11.1M	–	325
2021 Q4	$11.1M	Sell	119,426 -125,969	-51%	-$8.3M	0.39%	60
2021 Q3	$14.6M	Sell	245,395 -6,021	-2%	-$356K	0.54%	57
2021 Q2	$17.1M	Sell	251,416 -36,543	-13%	-$2.38M	0.61%	53
2021 Q1	$20M	Sell	287,959 -1,973	-0.7%	-$152K	0.65%	48
2020 Q4	$22.3M	Buy	+289,932	New	+$21.7M	0.78%	44

Rice Hall James & Associates's ARNA Position: Q1 2022 in Review

Rice Hall James & Associates sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 119,426 shares — an estimated $11.1M sold.

Rice Hall James & Associates first reported a position in ARNA in Q4 2020 and held it in 5 quarters. The position peaked at $22.3M in Q4 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Rice Hall James & Associates reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Rice Hall James & Associates sold 119,426 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $11.1M.
Rice Hall James & Associates first reported a position in Arena Pharmaceuticals Inc in Q4 2020 and held it in 5 quarters.
Rice Hall James & Associates's Arena Pharmaceuticals Inc position peaked at $22.3M in Q4 2020.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Rice Hall James & Associates's 13F filing for Q1 2022, filed 5 May 2022.